- -

Emerging therapeutic agents in osteoarthritis

RiuNet: Institutional repository of the Polithecnic University of Valencia

Share/Send to

Cited by


Emerging therapeutic agents in osteoarthritis

Show full item record

Alcaraz Tormo, MJ.; Guillen Salazar, MI.; Ferrándiz Manglano, ML. (2019). Emerging therapeutic agents in osteoarthritis. Biochemical Pharmacology. 165:4-16. https://doi.org/10.1016/j.bcp.2019.02.034

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10251/144825

Files in this item

Item Metadata

Title: Emerging therapeutic agents in osteoarthritis
Author: Alcaraz Tormo, Mª José Guillen Salazar, Mª Isabel Ferrándiz Manglano, Mª Luisa
Issued date:
[EN] Osteoarthritis (OA) is the most common joint disorder and a leading cause of disability. Current treatments for OA can improve symptoms but do not delay the progression of disease. In the last years, much effort has ...[+]
Subjects: Osteoarthritis , Pain , Inflammatory mediators , Structural alterations , Nerve growth factor , Wnt , ADAMTS , Cathepsin K , Fibroblast growth factor-18 , Cellular therapy
Copyrigths: Cerrado
Biochemical Pharmacology. (issn: 0006-2952 )
DOI: 10.1016/j.bcp.2019.02.034
Publisher version: https://doi.org/10.1016/j.bcp.2019.02.034
Project ID:
info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016/SAF2017-85806-R/ES/MECANISMOS REGULADORES DE LA INFLAMACION Y SU RESOLUCION EN ENFERMEDADES CRONICAS ARTICULARES Y DE LA PIEL/
This work has been funded by grant SAF2017-85806-R (Ministerio de Ciencia, Educacion y Universidades, Spain, FEDER).
Type: Artículo



This item appears in the following Collection(s)

Show full item record